James Armitage - Jun 15, 2023 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ James Armitage
Stock symbol
CRDF
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 05:06 PM
Previous filing
Oct 11, 2022
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +27.7K +30.92% $0.00 117K Jun 15, 2023 Common Stock 27.7K $1.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.